Skip to content
evidenceevidencedocumentFederal Criminal TrialGovernment Exhibit 291Contains an April 2010 email sending Walgreens three reports described as independent pharmaceutical-company due-diligence or validation reports. The attached materials included reports bearing Pfizer, Schering-Plough, GSK, and Theranos logos and a version of the Theranos multiplexed-panel validation report.
← All Evidence
Documents & Records

Government Exhibit 291

Contains an April 2010 email sending Walgreens three reports described as independent pharmaceutical-company due-diligence or validation reports. The attached materials included reports bearing Pfizer, Schering-Plough, GSK, and Theranos logos and a version of the Theranos multiplexed-panel validation report.

7 proceedings7 mentions1 trial
Also known as (7)
  • Holmes email to Walgreens attaching reports described as independent due-diligence reports, including a Theranos study report bearing a Pfizer logo
  • Walgreens email and attached version of the Theranos multiplexed-panel validation report
  • Exhibit 291, Holmes email transmitting a report bearing GSK and Theranos logos to Walgreens representatives
  • Trial Exhibit 291, Theranos-prepared pharmaceutical reports sent to Walgreens
  • Exhibit 291
  • April 2010 email sending Walgreens three reports described as independent due-diligence reports from pharmaceutical companies
  • Pharmaceutical report bearing Pfizer and Schering-Plough logos that was sent to Walgreens

Trial Record (7)